Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF

Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF

Objectives COMMANDER-HF was a randomised trial comparing rivaroxaban 2.5 mg two times a day to placebo, in addition to antiplatelet therapy, in patients hospitalised for worsening heart failure with coronary artery disease and sinus rhythm. Patients with diabetes are at increased risk of cardiovascu...

Full description

Bibliographic Details
Main Authors: João Pedro Ferreira, Faiez Zannad, Carolyn S P Lam, Dirk J van Veldhuisen, Fausto J Pinto, Daniel Caldeira, John Cleland, Barry Greenberg, Stefan D Anker, Mandeep R Mehra, Abhinav Sharma, Amir Razaghizad
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/8/e068865.full

Internet

https://bmjopen.bmj.com/content/13/8/e068865.full

Similar Items